Medical Condition News

RSS

RADAR-CNS programme aims to improve lives of patients with brain disorders

A major new research program supported by the Innovative Medicines Initiative launches today, which will develop new ways of monitoring major depressive disorder, epilepsy, and multiple sclerosis using wearable devices and smartphone technology.

27 Apr 2016

Rapamycin drug could target neural damage linked to Leigh syndrome

Salk Institute scientists showed how an FDA-approved drug boosts the health of brain cells by limiting their energy use. Like removing unnecessary lighting from a financially strapped household to save on electricity bills, the drug--called rapamycin--prolongs the survival of diseased neurons by forcing them to reduce protein production to conserve cellular energy.

27 Apr 2016

New method measures LCO in person's standing posture to diagnose neuromuscular disorders

A new technique might be used to diagnose neuromuscular disorders such as multiple sclerosis or impairment from concussions by detecting and measuring subtle oscillations in a person's standing posture.

27 Apr 2016

Investigators explore possible causes for cancer recurrence after LRC

Although laparoscopic radical cystectomy (LRC) and robotic assisted radical cystectomy (RARC) continue to grow in popularity and are successful in the treatment of bladder cancer, they are still considered experimental approaches. Using data collected by the Section of Uro-Technology of the European Association of Urology (ESUT), a team of researchers found that about 5% of patients experienced unexpected relapses of cancer after LRC, even with favorable pathology.

27 Apr 2016

Study reveals new function for CACNA1C gene in psychiatric diseases

A new study shows the death of newborn brain cells may be linked to a genetic risk factor for five major psychiatric diseases, and at the same time shows a compound currently being developed for use in humans may have therapeutic value for these diseases by preventing the cells from dying.

27 Apr 2016

Review focuses on autologous cell therapy that can be applied to cardiac surgery

The combination of cell and gene therapy is rapidly raising clinical interest, although their combination has been under investigation for several decades. This is mainly due to the availability and feasibility of clinically relevant gene delivery options. This review focuses on cell therapies for heart failure and their use combined with cardiac surgery as well as with gene therapy.

27 Apr 2016

Lilly's ixekizumab (Taltz) granted EC marketing authorisation for treatment of plaque psoriasis

Eli Lilly and Company announced today that the European Commission has granted marketing authorisation for ixekizumab (Taltz) for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union (EU) who are candidates for systemic therapy.

27 Apr 2016

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Protea Biosciences Group, Inc. announced today that it had entered into an exclusive license agreement with Yale University for new technology to improve the differential diagnosis of malignant melanoma.

27 Apr 2016

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

Two London students, who have invented separate pieces of medical technology that could help revolutionise the lives of people with Parkinson’s disease, could soon see their innovative devices available to millions of sufferers after they were shortlisted for a prestigious award.

27 Apr 2016

University of Leicester-led researchers solve 3D structure of NuRD complex that plays role in cancer

A team of researchers led by the University of Leicester has shed new light on how the regulation machinery that controls gene expression works by characterising a complex known as the NuRD complex.

27 Apr 2016

Sense announces official launch of new deafblind awareness e-learning course for audiologists

Sense, the national deafblind charity, has today announced the official launch of its new deafblind awareness e-learning course, specifically designed for audiologists.

27 Apr 2016

Regular aspirin use may help reduce risk of bile duct cancer

Regular use of aspirin was linked with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, in a recent study. The findings, which are published in the journal Hepatology, indicate that additional research on the potential of aspirin for preventing bile duct cancer is warranted.

27 Apr 2016

New fruit fly model study reveals metabolic pathway that can be targeted to treat FXS patients

Fragile X syndrome (FXS) is the most common genetically inherited cause of intellectual disability in humans. New research shows how the hormone insulin -- usually associated with diabetes -- is involved in the daily activity patterns and cognitive deficits in the fruitfly model of FXS, according to a new study from the Perelman School of Medicine at the University of Pennsylvania published online this month in Molecular Psychiatry in advance of the print issue.

27 Apr 2016

International researchers make crucial discovery on formation, growth of blood vessels

As blood vessels grow, the cells that compose them must make a choice between forming side-branches or expanding the vessel surface and increasing its diameter. Now Prof. Holger Gerhardt at the Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association and his international research teams have made a crucial disovery about this process: the cells can behave as a collective, moving in the same direction together.

27 Apr 2016

HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation

The addition of a house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet to maintenance medications improved time to first moderate or severe asthma exacerbation during a period of inhaled corticosteroid (ICS) reduction among adults with HDM allergy-related asthma not well controlled by ICS, according to a study appearing in the April 26 issue of JAMA.

27 Apr 2016

Scientists unravel mystery of disrupted communication between brain cells in Parkinson's patients

A possible cause has been found for the disrupted communication between brain cells exhibited by Parkinson's patients. Bettina Schwab, a researcher at the University of Twente in The Netherlands, discovered that this group of patients have increased concentrations of a certain type of protein. Ms Schwab defended her doctoral dissertation on Friday 22 April.

27 Apr 2016

Researchers test potential positive effects of micro-injury in mice modeled with AD

Researchers testing the potential positive effects of "micro-injury" by brief insertion of a small needle into the hippocampal region of mice modeled with Alzheimer's disease (AD) have found that the procedure not only stimulated the hippocampus into regenerative activity, but also reduced β-amyloid plaques, a hallmark of AD.

27 Apr 2016

ATR-FTIR spectroscopy could be effective for detecting ulcerative colitis

A minimally invasive screening for ulcerative colitis, a debilitating gastrointestinal tract disorder, using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body, according to researchers at Georgia State University.

27 Apr 2016

First small molecule targeted therapy holds promise for Usher syndrome

Usher syndrome (USH) is characterized by hearing loss or deafness at birth and progressive vision loss, and is the most common cause of inherited dual sensory deficit. No treatment is currently available to stop or slow the progression of vision or hearing loss in USH3, one of three clinical classifications for USH that are further divided into subtypes and all associated with different genes.

27 Apr 2016

OSMR gene plays key role in driving growth of glioblastoma tumors

Glioblastoma is the most aggressive type of brain tumor in adults. Unfortunately, there are no effective treatments for the disease. On average, patients succumb just 16 months after diagnosis.

27 Apr 2016

Medical Condition News

RADAR-CNS programme aims to improve lives of patients with brain disorders

Rapamycin drug could target neural damage linked to Leigh syndrome

New method measures LCO in person's standing posture to diagnose neuromuscular disorders

Investigators explore possible causes for cancer recurrence after LRC

Study reveals new function for CACNA1C gene in psychiatric diseases

Review focuses on autologous cell therapy that can be applied to cardiac surgery

Lilly's ixekizumab (Taltz) granted EC marketing authorisation for treatment of plaque psoriasis

Protea signs license agreement with Yale to develop new technology for detecting malignant melanoma

Two London students make innovative medical devices to improve lives of people with Parkinson’s disease

University of Leicester-led researchers solve 3D structure of NuRD complex that plays role in cancer

Sense announces official launch of new deafblind awareness e-learning course for audiologists

Regular aspirin use may help reduce risk of bile duct cancer

New fruit fly model study reveals metabolic pathway that can be targeted to treat FXS patients

International researchers make crucial discovery on formation, growth of blood vessels

HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation

Scientists unravel mystery of disrupted communication between brain cells in Parkinson's patients

Researchers test potential positive effects of micro-injury in mice modeled with AD

ATR-FTIR spectroscopy could be effective for detecting ulcerative colitis

First small molecule targeted therapy holds promise for Usher syndrome

OSMR gene plays key role in driving growth of glioblastoma tumors

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Latest News